Composite pH predicts esomeprazole response in laryngopharyngeal reflux without typical reflux syndrome

Laryngoscope

Volumn 123, Issue 6, 2013, Pages 1483-1489

  Lien, Han Chung ^a,b,c   Wang, Chen Chi ^a   Liang, Wen Miin ^c   Sung, Fung Chang ^c,d   Hsu, Jeng Yuan ^a   Yeh, Hong Zen ^a,b   Chong, Kareen ^c   Chang, Chi Sen ^a,e  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Laryngopharyngeal reflux; pH parameter; proton pump inhibitors; treatment effectiveness

Indexed keywords

ESOMEPRAZOLE;

ADULT; ARTICLE; COHORT ANALYSIS; CONCOMITANT TYPICAL REFLUX SYNDROME; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; EPIGASTRIC FULLNESS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEADACHE; HUMAN; LARYNGOPHARYNGEAL REFLUX; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PH; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDOSCOPY, GASTROINTESTINAL; ENZYME INHIBITORS; ESOMEPRAZOLE SODIUM; ESOPHAGEAL PH MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROGEN-ION CONCENTRATION; LARYNGOPHARYNGEAL REFLUX; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYNDROME; TREATMENT OUTCOME;

EID: 84878117727     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23780     Document Type: Article

References (33)

1. Koufman JA, Wiener GJ, Wu WC, Castell DO,. Reflux laryngitis and its sequelae: the diagnostic role of ambulatory 24-hour pH monitoring. J Voice 1988; 2: 78-89.
2. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease. Gastroenterology 2008; 135: 1383-1391.
3. Qadeer MA, Phillips CO, Lopez AR, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006; 101: 2646-2654.
4. Vaezi MF,. Gastroesophageal reflux-related chronic laryngitis: con. Arch Otolaryngol Head Neck Surg 2010; 136: 908-909.
5. Koufman JA, Aviv JE, Casiano RR, Shaw GY,. Laryngopharyngeal reflux: position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002; 127: 32-35.
6. Merati AL, Lim HJ, Ulualp SO, Toohill RJ,. Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 2005; 114: 177-182.
7. Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006; 116: 254-260.
8. Burton LK Jr, Murray JA, Thompson DM,. Ear, nose, and throat manifestations of gastroesophageal reflux disease. Complaints can be telltale signs. Postgrad Med 2005; 117: 39-45.
9. Oyer SL, Anderson LC, Halum SL,. Influence of anxiety and depression on the predictive value of the reflux symptom index. Ann Otol Rhinol Laryngol 2009; 118: 687-692.
10. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R,; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920.
11. Lien HC, Chang CS, Yeh HZ, et al. Increasing prevalence of erosive esophagitis among Taiwanese aged 40 years and above: a comparison between two time periods. J Clin Gastroenterol 2009; 43: 926-932.
12. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR,. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-547.
13. Belafsky PC, Postma GN, Koufman JA,. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 2001; 111: 979-981.
14. Lien HC, Wang CC, Hsu JY, et al. Classical reflux symptoms, hiatus hernia and overweight independently predict pharyngeal acid exposure in patients with suspected reflux laryngitis. Aliment Pharmacol Ther 2011; 33: 89-98.
15. Hu WH, Wong NY, Lai KC, etal. Normal 24-hour ambulatory proximal and distal gastroesophageal reflux parameters in Chinese. Hong Kong Med J 2002; 8: 168-171.
16. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102-1111.
17. Williams RB, Ali GN, Wallace KL, Wilson JS, De Carle DJ, Cook IJ,. Esophagopharyngeal acid regurgitation: dual pH monitoring criteria for its detection and insights into mechanisms. Gastroenterology 1999; 117: 1051-1061.
18. Maldonado A, Diederich L, Castell D, Gideon RM, Katz PO,. Laryngopharyngeal reflux identified using a new catheter design: defining normal values and excluding artifacts. Laryngoscope 2003; 113: 349-355.
19. Belafsky PC, Postma GN, Koufman JA,. Validity and reliability of the reflux symptom index (RSI). J Voice 2002; 16: 274-277.
20. Lien HC, Wang CC, Liang WM, Chang CS,. Validation of reflux symptom index questionnaire in Taiwanese patients with reflux laryngitis. Gastroenterol J Taiwan 2011; 28: 68.
21. El-serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM,. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96: 979-983.
22. Ford CN,. Evaluation and management of laryngopharyngeal reflux. JAMA 2005; 294: 1534-1540.
23. Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005; 115: 1230-1238.
24. Oelschlager BK, Eubanks TR, Maronian N, et al. Laryngoscopy and pharyngeal pH are complementary in the diagnosis of gastroesophageal-laryngeal reflux. J Gastrointest Surg 2002; 6: 189-194.
25. Wang AJ, Liang MJ, Jiang AY, et al. Predictors of acid suppression success in patients with chronic laryngitis. Neurogastroenterol Motil 2012; 24: 432-437.
26. Siupsinskiene N, Adamonis K, Toohill RJ, Sereika R,. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients. J Laryngol Otol 2008; 122: 1206-1212.
27. Mastronarde JG, Anthonisen NR, Castro M, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360: 1487-1499.
28. Zerbib F, Guisset O, Lamouliatte H, Quinton A, Galmiche JP, Tunon-De-Lara JM,. Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. Am J Respir Crit Care Med 2002; 166: 1206-1211.
29. Shaheen NJ, Crockett SD, Bright SD, et al. Randomised clinical trial: high-dose acid suppression for chronic cough-a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33: 225-234.
30. Poelmans J, Feenstra L, Demedts I, Rutgeerts P, Tack J,. The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms. Am J Gastroenterol 2004; 99: 1419-1426.
31. Hicks DM, Ours TM, Abelson TI, Vaezi MF, Richter JE,. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002; 16: 564-579.
32. Vaezi MF, Hagaman DD, Slaughter JC, et al. Proton pump inhibitor therapy improves symptoms in postnasal drainage. Gastroenterology 2010; 139: 1887-1893.
33. Ulualp SO, Roland PS, Toohill RJ, Shaker R,. Prevalence of gastroesophagopharyngeal acid reflux events: an evidence-based systematic review. Am J Otolaryngol 2005; 26: 239-244.